FOB Price
Obtenir le dernier prix3 ~ 5 / Piece ( Negotiable )
|Minimum Order
Localité:
-
Prix de commande minimale:
Commande minimale:
200 Piece
Packaging Detail:
12pcs/box
Delivery Time:
1-30days
Supplying Ability:
10000 Piece per Day
Payment Type:
T/T, Western Union, PayPal
Personne àcontacter peter123-cn.baiyh.030742
Hangzhou, Zhejiang
Product Description
Interleukin*6
is mainly produced by Th2 cells and secreted by T lymphocytes, B
lymphocytes, fibroblasts, endothelial cells, keratinocytes,
hepatocytes and bone marrow cells. Its relative molecular weight is
*6kDa. It is a glycoprotein composed of **2 amino acid residues.
Interleukin*6 is the first biomarker to appear after inflammatory
reaction. In different inflammatory diseases, the content of
interleukin*6 is significantly different. The increased level of
interleukin*6 caused by bacterial infection is significantly higher
than that caused by non-bacterial infection, and the level of
interleukin*6 is directly proportional to the severity of
inflammation and infection. Interleukin*6 is also a sensitive early
warning index of sepsis, and has a good correlation with the
severity and prognosis of sepsis. As an inflammatory factor, the
level of interleukin*6 is also closely related to cardiovascular
and cerebrovascular diseases such as atherosclerosis and acute
myocardial infarction (AMI).
Indications for Use
The kit is used for quantitative determination of interleukin*6
(IL*6) in human serum, plasma or whole blood samples in
vitro.
Who Should Have the Interleukin*6 (IL*6)
Test?
Patients suffering from inflammatory conditions;Patients
with diabetes, stroke or with cardiovascular disease and
C***-infected patients. Interleukin*6 (IL*6) may be used to help
evaluate a person who has a condition associated with inflammation,
such as lupus or rheumatoid arthritis, or with infection, such as
sepsis. It may also be used in the evaluation of diabetes, stroke,
or cardiovascular disease.
Besides, Interleukin*6 (IL*6) Test Kit can help determine the risk
of developing severe coagulation-related consequences such as
disseminated intravascular coagulation (DIC) and acute respiratory
distress syndrome (ARDS) in severe cases of C**9
infection.
Combined with the highly specific PCT joint inspection, it can
early warning of sepsis, reflect the severity of infection,
evaluate the treatment effect, and help the clinic to quickly judge
the patient\'s situation
Accurate: the fluorescence
immunochromatography method based test kit has higher
accuracy.
Easier to read: based on
fluorescence immunochromatography, easier to read test result than
colloidal gold immunochromatography.
Easy for storage: it can be
stored at room temperature (4ºC~*0ºC).
Longer validity period: *8
months of validity period.
| Product Name | Interleukin*6 (IL*6) Test Kit (Fluorescence Immunochromatography) |
| Method | Fluorescence immunochromatography |
| Specimen | Whole blood, Plasma, Serum |
| Specification | *0 tests/box, *0 tests/box, *5 tests/box, *0 tests/box, *0 tests/box, **0 tests/box. |
| Components | Each pouch contains a test card and a desiccant; the test card is composed of a shell and a test strip, the test strip is composed of sample pad, fluorescent pad (fixed with fluorescent labeled IL*6 monoclonal antibody 1), nitrocellulose membrane (coated with IL*6 monoclonal antibody 2 and goat anti-mouse IgG), filter paper and PVC plastic plate |
| Test time | *5 mins |
Test
Procedure
Please read the
instructions of the test kit and the manual of the fluorescence
immunoanalyzer carefully before use.
a) Bring the
test kit and sample to be tested to room
temperature.
b) Make sure
the ID card matches the batch number of the kit, and insert the ID
card into the card reading area of the instrument to read the
information.
c) Open the
inner package of the test card, take out the test card; draw *5μL
of serum plasma sample, drop vertically to the test card sampling
place, and start timing; draw *5μL whole blood, vertically drop it
to the test card sampling place, and immediately add 1 drop whole
blood diluent at the sampling place and start
timing.
d) After adding the sample, click "Start
Test" on the screen of the fluorescence immunoanalyzer, and the
test card will react at room temperature for *5 minutes; insert the
test card into the test card slot of the fluorescence
immunoanalyzer, and the instrument will automatically test the test
card; The test results can be seen on the display screen of the
immunoassay analyzer. Click "Print" on the screen to print the
results.
Positive
Judgment Value or Reference
Interval
Normal reference
value:<7pg/mL.
Due to
differences in geography, race, gender and age, it is recommended
that each laboratory establish its own positive judgment value or
reference interval.
Test result
(For reference only, not used as clinical diagnostic criteria, test results need to be combined with other clinical and laboratory data for clinical diagnosis)
| Content of IL*6(pg/mL) | Clinical application suggestions |
| <7 | Normal value |
| ****0 | Indicates mild inflammation or mild infection. |
| ******0 | Suggests general bacterial infection or systemic inflammatory reaction. |
| >**0 | Suggests may be sepsis. |
Limitations
a) This test
kit is only for the test of human serum, plasma or whole blood
samples. Abnormal hematocrit samples have an impact on the results
of the whole blood test. The test results of serum, plasma and
whole blood are not significant difference when the hematocrit is
between *1% and *8%.
b) The test
results need to be combined with other clinical and laboratory
data, and if the IL*6 test results do not match the clinical
assessment, further testing is
required.
c) False
positive results can be caused by: cross-reaction of antibody-like
components in the blood; some non-specific components in blood have
similar antigenic determinants to capture fluorescent-labeled
antibodies, such as anisotropic antibodies and rheumatoid factors.
In view of the above reasons, the test results should be combined
with the patient\'s medical history and other laboratory results
performed.
d) Hemoglobin,
triglycerides and bilirubin in the blood sample can interfere with
the test results, where the maximum allowable concentrations are
5g/L, *0g/L and 0.2g/L,
respectively.
e) False
positive results can be caused by: some unknown components shield
the antigenic determinants from binding to the antibody; the
unstable IL*6 antigen gradually degrades with time and temperature
and cannot be recognized by the antibody. Valid test results depend
on a good reagent and sample storage
environment.
f) Other
factors, including technical reasons, operational errors and other
sample factors, may also cause errors in test
results.
Certificate
CE ISO****5
